HIGHLIGHTS
- who: Sina M. Coldewey from the Department of Anaesthesiology and Intensive Care Medicine, Jena University Hospital, Am Klinikum, Jena, Germany have published the research work: Infliximab in the treatment of patients with severe COVID-19 (INFLIXCOVID): protocol for a randomised, controlled, multicentre, open-label phase II clinical study, in the Journal: (JOURNAL) of 11/06/2021
- what: The overall aim of this randomised, controlled, multicentre, open-label phase II clinical trial is the improvement of the survival of patients with COVID-19 at high risk for severe disease by repurposing a clinically established and globally . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.